Infectious Disease Models and Innovative Therapies (IDMIT) France

Research

Date range: 1 July 2021 - 30 June 2022

Region: Global
Subject/journal group: All

The table to the right includes counts of all research outputs for Infectious Disease Models and Innovative Therapies (IDMIT) published between 1 July 2021 - 30 June 2022 which are tracked by the Nature Index.

Hover over the donut graph to view the Share for each subject. Below, the same research outputs are grouped by subject. Click on the subject to drill-down into a list of articles organized by journal, and then by title.

Note: Articles may be assigned to more than one subject area.

Article Count and Share for Infectious Disease Models and Innovative Therapies (IDMIT)
Count Share
1 0.05

Outputs by subject (Share)

Outputs by subject
Subject Count Share
1 0.05

Share output for the past 5 years

Share per year
2017 2018 2019 2020 2021
0.06 0.00 0.13 0.08 0.05

Compare Infectious Disease Models and Innovative Therapies (IDMIT) with other institutions

Collaboration

Date range: 1 July 2021 - 30 June 2022

International vs. domestic collaboration by Share

  • 17.76% Domestic
  • 82.24% International

Hover over the graph to view the percentage of collaboration.


Top 10 domestic collaborators with Infectious Disease Models and Innovative Therapies (IDMIT) by Share (6 total)

  1. Infectious Disease Models and Innovative Therapies (IDMIT) and Centre de Recherche en Immunologie des Infections Virales et des Maladies Auto-immunes (IMVA) (0.10)
    Infectious Disease Models and Innovative Therapies (IDMIT)0.05
    Centre de Recherche en Immunologie des Infections Virales et des Maladies Auto-immunes (IMVA)0.05
  2. Infectious Disease Models and Innovative Therapies (IDMIT) and National Institute for Health and Medical Research (INSERM) (0.08)
    Infectious Disease Models and Innovative Therapies (IDMIT)0.05
    National Institute for Health and Medical Research (INSERM)0.03
  3. Infectious Disease Models and Innovative Therapies (IDMIT) and The French Alternative Energies and Atomic Energy Commission (CEA) (0.08)
    Infectious Disease Models and Innovative Therapies (IDMIT)0.05
    The French Alternative Energies and Atomic Energy Commission (CEA)0.03
  4. Infectious Disease Models and Innovative Therapies (IDMIT) and University of Paris-Sud (UPSud) (0.08)
    Infectious Disease Models and Innovative Therapies (IDMIT)0.05
    University of Paris-Sud (UPSud)0.03
  5. Infectious Disease Models and Innovative Therapies (IDMIT) and Pasteur Institute (0.06)
    Infectious Disease Models and Innovative Therapies (IDMIT)0.05
    Pasteur Institute0.01
  6. Infectious Disease Models and Innovative Therapies (IDMIT) and French Research Agency ANRS (0.06)
    Infectious Disease Models and Innovative Therapies (IDMIT)0.05
    French Research Agency ANRS0.01

Top 10 international collaborators with Infectious Disease Models and Innovative Therapies (IDMIT) by Share (10 total)

  1. Infectious Disease Models and Innovative Therapies (IDMIT) and Amsterdam UMC (0.76)
    Infectious Disease Models and Innovative Therapies (IDMIT)0.05
    Amsterdam UMC0.71
  2. Infectious Disease Models and Innovative Therapies (IDMIT) and University of Amsterdam (UvA) (0.41)
    Infectious Disease Models and Innovative Therapies (IDMIT)0.05
    University of Amsterdam (UvA)0.35
  3. Infectious Disease Models and Innovative Therapies (IDMIT) and VU Amsterdam (0.41)
    Infectious Disease Models and Innovative Therapies (IDMIT)0.05
    VU Amsterdam0.35
  4. Infectious Disease Models and Innovative Therapies (IDMIT) and Tergooi Hospital (0.12)
    Infectious Disease Models and Innovative Therapies (IDMIT)0.05
    Tergooi Hospital0.07
  5. Infectious Disease Models and Innovative Therapies (IDMIT) and Netherlands Ministry of Health, Welfare and Sport (VWS) (0.09)
    Infectious Disease Models and Innovative Therapies (IDMIT)0.05
    Netherlands Ministry of Health, Welfare and Sport (VWS)0.03
  6. Infectious Disease Models and Innovative Therapies (IDMIT) and Public Health Service Amsterdam (GGD) (0.09)
    Infectious Disease Models and Innovative Therapies (IDMIT)0.05
    Public Health Service Amsterdam (GGD)0.03
  7. Infectious Disease Models and Innovative Therapies (IDMIT) and The Peter Doherty Institute for Infection and Immunity (Doherty Institute) (0.09)
    Infectious Disease Models and Innovative Therapies (IDMIT)0.05
    The Peter Doherty Institute for Infection and Immunity (Doherty Institute)0.03
  8. Infectious Disease Models and Innovative Therapies (IDMIT) and Cornell University (0.07)
    Infectious Disease Models and Innovative Therapies (IDMIT)0.05
    Cornell University0.02
  9. Infectious Disease Models and Innovative Therapies (IDMIT) and Melbourne Health (0.07)
    Infectious Disease Models and Innovative Therapies (IDMIT)0.05
    Melbourne Health0.02
  10. Infectious Disease Models and Innovative Therapies (IDMIT) and The University of Melbourne (UniMelb) (0.07)
    Infectious Disease Models and Innovative Therapies (IDMIT)0.05
    The University of Melbourne (UniMelb)0.02

Relationships

Partner Institutions

Infectious Disease Models and Innovative Therapies (IDMIT) is a research collaboration whose article contributions are accrued to its participating partner institutions below.